Novel N,N-dialkyl cyanocinnamic acids as monocarboxylate transporter 1 and 4 inhibitors

por Jonnalagadda, Shirisha, Jonnalagadda, Sravan K., Ronayne, Conor T., Nelson, Grady L., Solano, Lucas N., Rumbley, Jon, Holy, Jon, Mereddy, Venkatram R., Drewes, Lester R.
Publicado en Oncotarget (2019)

Coumarin carboxylic acids as monocarboxylate transporter 1 inhibitors: In vitro and in vivo studies as potential anticancer agents

por Gurrapu, Shirisha, Jonnalagadda, Sravan K., Alam, Mohammad A., Ronayne, Conor T., Nelson, Grady L., Solano, Lucas N., Lueth, Erica A., Drewes, Lester R., Mereddy, Venkatram R.
Publicado en Bioorg Med Chem Lett (2016)

Development of Novel Silyl Cyanocinnamic Acid Derivatives as Metabolic Plasticity Inhibitors for Cancer Treatment

por Nelson, Grady L., Ronayne, Conor T., Solano, Lucas N., Jonnalagadda, Sravan K., Jonnalagadda, Shirisha, Rumbley, Jon, Holy, Jon, Rose-Hellekant, Teresa, Drewes, Lester R., Mereddy, Venkatram R.
Publicado en Sci Rep (2019)

Synthesis, in vitro, and in vivo evaluation of novel N-phenylindazolyl diarylureas as potential anti-cancer agents

por Solano, Lucas N., Nelson, Grady L., Ronayne, Conor T., Jonnalagadda, Shirisha, Jonnalagadda, Sravan K., Kottke, Kaija, Chitren, Robert, Johnson, Joseph L., Pandey, Manoj K., Jonnalagadda, Subash C., Mereddy, Venkatram R.
Publicado en Sci Rep (2020)